RhumbLine Advisers’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-132,048
| Closed | -$2.62M | – | 4417 |
|
|
2023
Q1 | $2.62M | Buy |
132,048
+6,995
| +6% | +$121K | ﹤0.01% | 1670 |
|
|
2022
Q4 | $1.7M | Buy |
125,053
+7,730
| +7% | +$108K | ﹤0.01% | 1865 |
|
|
2022
Q3 | $1.63M | Buy |
117,323
+4,617
| +4% | +$68.6K | ﹤0.01% | 1870 |
|
|
2022
Q2 | $1.62M | Buy |
112,706
+7,171
| +7% | +$124K | ﹤0.01% | 1887 |
|
|
2022
Q1 | $2.38M | Buy |
105,535
+5,901
| +6% | +$115K | ﹤0.01% | 1719 |
|
|
2021
Q4 | $1.87M | Buy |
99,634
+566
| +0.6% | +$15.1K | ﹤0.01% | 1920 |
|
|
2021
Q3 | $3.25M | Sell |
99,068
-14,479
| -13% | -$540K | ﹤0.01% | 1611 |
|
|
2021
Q2 | $4.84M | Sell |
113,547
-4,387
| -4% | -$172K | 0.01% | 1444 |
|
|
2021
Q1 | $4.52M | Buy |
117,934
+1,235
| +1% | +$52.6K | 0.01% | 1460 |
|
|
2020
Q4 | $5.11M | Buy |
116,699
+7,706
| +7% | +$290K | 0.01% | 1345 |
|
|
2020
Q3 | $4.29M | Buy |
108,993
+436
| +0.4% | +$14.1K | 0.01% | 1264 |
|
|
2020
Q2 | $3.42M | Sell |
108,557
-5,180
| -5% | -$193K | 0.01% | 1425 |
|
|
2020
Q1 | $4M | Buy |
113,737
+2,640
| +2% | +$111K | 0.01% | 1162 |
|
|
2019
Q4 | $5.4M | Buy |
111,097
+5,796
| +6% | +$264K | 0.01% | 1210 |
|
|
2019
Q3 | $5M | Buy |
105,301
+3,105
| +3% | +$146K | 0.01% | 1179 |
|
|
2019
Q2 | $4.39M | Buy |
102,196
+1,063
| +1% | +$41.3K | 0.01% | 1271 |
|
|
2019
Q1 | $3.91M | Buy |
101,133
+57,041
| +129% | +$1.93M | 0.01% | 1323 |
|
|
2018
Q4 | $1.26M | Buy |
44,092
+14,311
| +48% | +$455K | ﹤0.01% | 1901 |
|
|
2018
Q3 | $1.17M | Sell |
29,781
-2,075
| -7% | -$76.7K | ﹤0.01% | 1936 |
|
|
2018
Q2 | $1.03M | Buy |
31,856
+280
| +0.9% | +$7.7K | ﹤0.01% | 1997 |
|
|
2018
Q1 | $692K | Sell |
31,576
-50
| -0.2% | -$1.2K | ﹤0.01% | 2093 |
|
|
2017
Q4 | $749K | Sell |
31,626
-6,442
| -17% | -$162K | ﹤0.01% | 2076 |
|
|
2017
Q3 | $1.07M | Buy |
38,068
+480
| +1% | +$14.6K | ﹤0.01% | 1932 |
|
|
2017
Q2 | $1.21M | Sell |
37,588
-530
| -1% | -$16.2K | ﹤0.01% | 1853 |
|
|
2017
Q1 | $1.08M | Buy |
38,118
+1,309
| +4% | +$34.8K | ﹤0.01% | 1873 |
|
|
2016
Q4 | $891K | Buy |
36,809
+2,586
| +8% | +$63.5K | ﹤0.01% | 1920 |
|
|
2016
Q3 | $812K | Sell |
34,223
-565
| -2% | -$12.4K | ﹤0.01% | 1936 |
|
|
2016
Q2 | $639K | Buy |
34,788
+3,185
| +10% | +$49.8K | ﹤0.01% | 2041 |
|
|
2016
Q1 | $328K | Buy |
31,603
+380
| +1% | +$3.85K | ﹤0.01% | 2487 |
|
|
2015
Q4 | $472K | Buy |
31,223
+2,025
| +7% | +$30.1K | ﹤0.01% | 2272 |
|
|
2015
Q3 | $462K | Buy |
29,198
+1,160
| +4% | +$29.2K | ﹤0.01% | 2279 |
|
|
2015
Q2 | $742K | Buy |
28,038
+1,520
| +6% | +$49.1K | ﹤0.01% | 2069 |
|
|
2015
Q1 | $1.03M | Buy |
26,518
+3,815
| +17% | +$131K | ﹤0.01% | 1839 |
|
|
2014
Q4 | $683K | Buy |
22,703
+125
| +0.6% | +$3.57K | ﹤0.01% | 2059 |
|
|
2014
Q3 | $534K | Sell |
22,578
-780
| -3% | -$22.2K | ﹤0.01% | 2166 |
|
|
2014
Q2 | $728K | Buy |
23,358
+2,098
| +10% | +$60.5K | ﹤0.01% | 2038 |
|
|
2014
Q1 | $676K | Buy |
21,260
+90
| +0.4% | +$2.97K | ﹤0.01% | 2031 |
|
|
2013
Q4 | $726K | Buy |
21,170
+1,830
| +9% | +$53.2K | ﹤0.01% | 2022 |
|
|
2013
Q3 | $388K | Sell |
19,340
-96
| -0.5% | -$2K | ﹤0.01% | 2366 |
|
|
2013
Q2 | $412K | Buy |
+19,436
| New | +$378K | ﹤0.01% | 2405 |
|
Other funds holding CSII
RhumbLine Advisers's CSII Position: Q2 2023 in Review
RhumbLine Advisers sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 132,048 shares — an estimated $2.62M sold.
RhumbLine Advisers first reported a position in CSII in Q2 2013 and held it in 40 quarters. The position peaked at $5.4M in Q4 2019. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- RhumbLine Advisers reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- RhumbLine Advisers sold 132,048 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $2.62M.
- RhumbLine Advisers first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 40 quarters.
- RhumbLine Advisers's Cardiovascular Systems, Inc. position peaked at $5.4M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.